Cytarabine is a chemotherapy drug for treating acute leukemias such as acute myeloid leukemia. Doctors also use it for some lymphomas, including Hodgkin lymphoma. Healthcare professionals often ...

Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in higher ...

Cytarabine is a chemotherapy agent, prescribed for acute myeloid leukemia (AML) and non-Hodgkin lymphoma. The risk or severity of adverse effects can be increased when Cytarabine is combined with ...

Annamycin, a chemotherapy drug with zero cardiotoxicity, is being tested for relapsed or refractory AML in the phase 3 MIRACLE trial. The trial, active in the U.S., Europe, and the Middle East, ...

Indium-111–Capromab Pendetide Radioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men After Failed Prostatectomy Purpose: Troxacitabine has activity ...

March 16, 2011 — High doses of cytarabine are more effective than conventional doses in inducing relapse-free survival in patients with acute myeloid leukemia (AML). Now, data suggest that an ...

The appraisal committee considered evidence submitted by Jazz Pharmaceuticals and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the ...

Discover comprehensive details about Cytarabine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The appraisal committee considered evidence submitted by AbbVie, a review of this submission by the evidence review group (ERG), and responses from stakeholders. See the committee papers for full ...

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials This phase III, open-label study ...